retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 Trial of for Obesity Retatrutide Triple Agonist Research Peptide
Description
Here's roughly what to expect at each stage
The side effects look similar in shape, with nausea and stomach symptoms leading the pack for both
The safest way to stop taking GLP-1 medications is to do so under the guidance of your doctor
Source: IQVIA LAAD pharmacy claims
Either way, it has proven effective in lowering blood sugar for people with Type 2 diabetes
Check our semaglutide dosage in units guide and the semaglutide dosage calculator for precise measurements
